Isotope effect and pressure dependence of the freezing temperature in proton glasses.

Tadić,Pirc,Blinc

DOI: https://doi.org/10.1103/PHYSREVB.37.679

Abstract:

What problem does this paper attempt to address?

Lumican affects tumor cell functions, tumor–ECM interactions, angiogenesis and inflammatory response

Dragana Nikitovic,Antonis Papoutsidakis,Nikos K. Karamanos,George N. Tzanakakis

DOI: https://doi.org/10.1016/j.matbio.2013.09.003

IF: 10.447

2014-04-01

Matrix Biology

Abstract:The consecutive steps of tumor growth, local invasion, intravasation, extravasation and invasion of anatomically distant sites are obligatorily perpetrated through specific interactions of the tumor cells with their microenvironment. Lumican, a class II small leucine-rich proteoglycans (SLRP) has been designated key roles both in extracellular matrix (ECM) organization and as an important modulator of biological functions. This review will critically discuss lumicans' roles in tumor development and progression. We will especially focus on correlating lumicans' expression and distribution in tumor tissues with: (1) the organization of the tumor matrices; (2) tumor cell signaling and functions; (3) tumor cell-matrix interface; (4) tumor angiogenesis; and (5) lumicans' potential roles in tumor-associated inflammatory response. Present knowledge of lumicans' biology provides a fundamental platform upon which to build and deepen our understanding of lumican function in tumorigenesis in order to be able to design credible anti-tumor approaches.

cell biology,biochemistry & molecular biology
Multi-omics analysis reveals the prognostic and tumor micro-environmental value of lumican in multiple cancer types

Zehuai Guo,Zeyun Li,Ming Chen,Xiangjun Qi,Zhe Sun,Siqi Wu,Xuenan Hou,Mengli Qiu,Yang Cao

DOI: https://doi.org/10.3389/fmolb.2023.1158747

IF: 6.113

2023-08-25

Frontiers in Molecular Biosciences

Abstract:Background: Lumican (LUM), a proteoglycan of the extracellular matrix, has been reported to be involved in the regulation of immune escape processes, but the data supporting this phenomenon are not sufficient. In this study, we aimed to explore the links among LUM expression, survival, tumor microenvironment (TME), and immunotherapy in 33 cancer types. Methods: Data from several databases, such as UCSC Xena, GTEx, UALCAN, HPA, GEPIA2, TISIDB, PrognoScan, TIMER2, and GEO, as well as published studies, were used to determine the relationship between LUM expression and clinical features, TME, heterogeneity, and tumor stemness. Results: The expression of LUM was statistically different in most tumors versus normal tissues, both at the RNA and protein expression levels. High expression of LUM was typically associated with a poor prognosis in tumors. Additionally, immune scores, six immune cells, four immunosuppressive cells, cancer-associated fibroblasts (CAFs)-associated and immunosuppressive factors, tumor mutation burden (TMB), microsatellite instability (MSI), DNAss, and RNAss were all significantly associated with LUM. Among them, LUM expression displayed a significant positive correlation with CAFs and their factors, and exhibited immunosuppressive effects in six independent immunotherapy cohorts. Conclusion: Multi-omics analysis suggests that LUM may have been a prognostic marker, contributed to immunosuppression in the TME, and decreased the effectiveness of immune checkpoint inhibitors.

biochemistry & molecular biology
Proteomic and Phosphoproteomic Maps of Lung Squamous Cell Carcinoma from Chinese Patients.

Lulu Pan,Xijun Wang,Longhai Yang,Lei Zhao,Linhui Zhai,Junyu Xu,Yikun Yang,Yousheng Mao,Shujun Cheng,Ting Xiao,Minjia Tan

DOI: https://doi.org/10.3389/fonc.2020.00963

IF: 4.7

2020-01-01

Frontiers in Oncology

Abstract:Lung squamous cell carcinoma (LUSC) is one of the leading causes of tumor-driven deaths in the world. To date, studies on the tumor heterogeneity of LUSC at genomic level have only revealed limited therapeutic benefits. Therefore, system-wide research of LUSC at proteomic level may further improve precision medicine strategies on individual demands. To this end, we performed proteomic and phosphoproteomic study for LUSC samples of 25 Chinese patients. From our results, two subgroups (Cluster I and II) based on proteomic data were identified, which were associated with distinct molecular characteristics and clinicopathologic features. Combined with phosphoproteomic data, our result showed that spliceosome pathway was enriched in Cluster I, while focal adhesion pathway, immune-related pathways and Ras signaling pathway were enriched in Cluster II. In addition, we found that lymph node metastasis (LNM) was associated with our proteomic subgroups and cell cycle pathway was enriched in patients with LNM. Further analysis showed that MCM2, a DNA replication licensing factor involved in cell cycle pathway, was highly expressed in patients with poor prognosis, which was further proved by immunohistochemistry (IHC) analysis. In summary, our study provided a resource of the proteomic and phosphoproteomic features of LUSC in Chinese patients.
Psychiatric Commitment of the Elderly

K. Blank,W. Vingiano,H. I. Schwartz

DOI: https://doi.org/10.1177/089198878900200304

1989-07-01

Journal of Geriatric Psychiatry and Neurology

Abstract:Involuntary hospitalization of the elderly has been the focus of controversy. In many jurisdictions, commitment criteria are stringently and narrowly defined, require a showing of "dangerousness," and are difficult to apply toward securing proper treatment for the elderly. In other areas, broader criteria apply, but some authors argue that such criteria are inappropriately used with the elderly and leave them vulnerable to the abuse of unnecessary institutionalization. The authors examined 274 consecutive admissions aged 55 years and over, comparing voluntary and involuntary patients. Patients admitted involuntarily were significantly more likely to have organic mental disorders, be violent before admission, and be disoriented, withdrawn, and apathetic. Voluntary patients were significantly more likely to have major mood disorders. Patients who lived with others were more likely to be committed than those living alone. The authors discuss these findings with attention to the appropriateness of broader commitment standards and the more stringent dangerousness criteria as they apply to the geriatric population. ( J Geriatr Psychiatry Neurol 1989; 2:140-144).
Lumican deficiency promotes pulmonary arterial remodeling

Ying-Ju Lai,Winston W-Y Kao,Yung-Hsin Yeh,Wei-Jan Chen,Pao-Hsien Chu

DOI: https://doi.org/10.1016/j.trsl.2021.05.007

IF: 10.171

2021-11-01

Translational Research

Abstract:<p>Pulmonary arterial hypertension (PAH) is caused by progressive extracellular matrix disorganization and increased pulmonary vascular cell proliferation. Lumican is a member of the small leucine-rich proteoglycan (SLRP) family that controls cell proliferation, and is a potential endogenous modulator of TGF-β signaling pathway. We show that the decreased lumican protein levels in pulmonary arterial smooth muscle cells (PASMCs) is related to the vascular remodeling and stiffening observed in PAH. The role of lumican in PASMC accumulation and activation in response to pulmonary vascular remodeling remains unclear and we hypothesized that the loss of lumican in PASMCs promotes the development of PAH. Our aim was to establish that lumican plays a pivotal role in modulating pathological vascular remodeling in humans using a rat model of monocrotaline (MCT)-induced PAH and chronically hypoxic mice. We found that mice with a homozygous deletion of lumican (Lum-/-) showed severe pulmonary arterial remodeling and right ventricular hypertrophy in response to hypoxia, and these effects in mice with chronic hypoxia-induced pulmonary hypertension were successfully treated by the administration of a lumican C-terminal peptide (LumC13C-A, lumikine). We identified a mechanistic link by which lumican signaling prevents the activation of phosphorylated AKT, resulting in the suppression of PASMC proliferation. Lumican deficiency promotes pulmonary arterial remodeling. Administration of lumikine reverses the PAH pathogenesis caused by hypoxia-induced experimental PAH. Lumican is an antiproliferative target that functions to suppress pAKT activation during pathogenesis.</p>

medicine, general & internal,medical laboratory technology, research & experimental
Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment.

Elizabeth V. Nguyen,Brooke A. Pereira,Mitchell G. Lawrence,Xiuquan Ma,Richard J. Rebello,Howard Chan,Birunthi Niranjan,Yunjian Wu,Stuart Ellem,Xiaoqing Guan,Jianmin Wu,Joanna N. Skhinas,Thomas R. Cox,Gail P. Risbridger,Renea A. Taylor,Natalie L. Lister,Roger J. Daly

DOI: https://doi.org/10.1074/mcp.ra119.001496

IF: 7.381

2019-01-01

Molecular & Cellular Proteomics

Abstract:In prostate cancer, cancer-associated fibroblasts (CAF) exhibit contrasting biological properties to non-malignant prostate fibroblasts (NPF) and promote tumorigenesis. Resolving intercellular signaling pathways between CAF and prostate tumor epithelium may offer novel opportunities for research translation. To this end, the proteome and phosphoproteome of four pairs of patient-matched CAF and NPF were characterized to identify discriminating proteomic signatures. Samples were analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) with a hyper reaction monitoring data-independent acquisition (HRM-DIA) workflow. Proteins that exhibited a significant increase in CAF versus NPF were enriched for the functional categories "cell adhesion" and the "extracellular matrix." The CAF phosphoproteome exhibited enhanced phosphorylation of proteins associated with the "spliceosome" and "actin binding." STRING analysis of the CAF proteome revealed a prominent interaction hub associated with collagen synthesis, modification, and signaling. It contained multiple collagens, including the fibrillar types COL1A1/2 and COL5A1; the receptor tyrosine kinase discoidin domain-containing receptor 2 (DDR2), a receptor for fibrillar collagens; and lysyl oxidase-like 2 (LOXL2), an enzyme that promotes collagen crosslinking. Increased activity and/or expression of LOXL2 and DDR2 in CAF were confirmed by enzymatic assays and Western blotting analyses. Pharmacological inhibition of CAF-derived LOXL2 perturbed extracellular matrix (ECM) organization and decreased CAF migration in a wound healing assay. Further, it significantly impaired the motility of co-cultured RWPE-2 prostate tumor epithelial cells. These results indicate that CAF-derived LOXL2 is an important mediator of intercellular communication within the prostate tumor microenvironment and is a potential therapeutic target.
Lumican suppresses cell proliferation and aids Fas-Fas ligand mediated apoptosis: implications in the cornea

Neeraj Vij,Luke Roberts,Sarah Joyce,Shukti Chakravarti

DOI: https://doi.org/10.1016/j.exer.2003.12.006

Abstract:Lumican, an extracellular matrix (ECM) keratan sulfate proteoglycan, binds fibrillar collagen and limits collagen fibril diameter in the cornea, skin and tendon. Lumican-deficient mice (Lum(-/-)) develop abnormally thick collagen fibrils, translucent corneas and fragilities of the skin and the tendon. In addition to modulating interstitial ECM structure, here we hypothesized that lumican regulates proliferation and apoptosis of cells residing in the interstitium. Corneal and embryonic fibroblasts from the Lum(-/-) mouse show increased growth in culture. Lum(-/-) mouse embryonic fibroblasts (MEF), compared to their wild type counterparts, display increased rates of proliferation and decreased apoptosis. Ectopic expression of lumican in Lum(-/-) MEF or exogenous recombinant lumican in the culture medium reduces proliferation to rates seen in the Lum(+/+) MEF. We further investigated the implications of lumican's proliferation and apoptosis regulatory role in the cornea where lumican is a major component of the stromal matrix. Stromal keratocytes undergo proliferation and apoptosis during corneal maturation and in the healing of injured cornea. The Lum(-/-) mouse shows increased proliferation and decreased apoptosis of stromal keratocytes during postnatal corneal maturation at the 10-day age. Apoptosis is also significantly down regulated in Lum(-/-) vis-à-vis Lum(+/+) mice during stromal wound healing in the adult 6-week age. Lumican appears to regulate these cellular functions by modulating specific cell growth and apoptosis mediators. Thus, Lum(-/-) MEF have decreased p21(WAF1/CIP1), a universal inhibitor of cyclin-dependent kinases and a consequent increase in cyclins A, D1 and E. Furthermore, the tumor suppressor p53, an upstream regulator of p21 is down regulated in the MEF and the cornea of Lum(-/-) mice. The evidence suggests regulation of p21 by lumican in a p53-dependent way. The MEF and the cornea of Lum(-/-) mice also show a dramatic decrease in Fas (CD95). The Lum(-/-) MEF fail to induce Fas upon treatment with Fas ligand. Fas-Fas ligand interaction is an initiating event in apoptosis and its disruption in lumican-deficiency may partly explain the observed decrease in apoptosis. Fas-Fas ligand mediated apoptosis is critical for maintaining the immune privileged status of the cornea, which implies a new and exciting role for lumican in the cornea.
Exploring molecular structure by virtual reality.

Michael J. Hartshorn,Pawel Herzyk,Roderick E. Hubbard

DOI: https://doi.org/10.1016/S0167-7799(00)88911-8

1995-03-01

Trends in Biotechnology

Abstract:
Mechanisms of Tumor-Lymphatic Interactions in Invasive Breast and Prostate Carcinoma

Leticia Oliveira-Ferrer,Karin Milde-Langosch,Kathrin Eylmann,Maila Rossberg,Volkmar Müller,Barbara Schmalfeldt,Isabell Witzel,Jasmin Wellbrock,Walter Fiedler

DOI: https://doi.org/10.3390/ijms21020602

2020-01-17

Abstract:During the last few years, diverse studies have shown that tumors can actively interact with the lymphatic system and promote metastases development. In order to examine the molecular mechanisms involved in this interaction, we co-cultured tumor and lymphatic endothelial cells (LEC) and subsequently analyzed the molecular alterations of LECs. Therefore, LECs were co-cultivated with either a highly or weakly metastatic breast cancer cell line using contact (mixture) and non-contact (transwell) co-cultures. mRNA profiles from LECs were subsequently analyzed for genes specifically induced by highly metastatic tumor cells ("metastatic specific"). Among the up-regulated "metastatic specific" genes, we found candidates involved in cell cycle, cell adhesion and motility (BST2, E-selectin, and HMMR), cytokines (CCL7, CXCL6, CXCL1, and CSF2) and factors of the complement system (C1R, C3, and CFB). Among the down-regulated genes, we detected the hyaluronan receptor STAB2, angiogenic factor apelin receptor (APLNR), and the glycosylation enzyme MAN1A1. In an additional prostate cancer co-culture model, we could confirm a "metastatic specific" upregulation of E-selectin and CCL7 in LECs after interaction with the prostate cancer cell lines LNCAP (highly metastatic) and DU145 (weakly metastatic). These data allowed us to identify a set of genes regulated in LECs during in vitro communication with cancer cells, which might subsequently facilitate lymphatic metastasis.
Cloning and upstream sequence of a juvenile hormone-regulated gene from the migratory locust.

J. Zhang,G. R. Wyatt

DOI: https://doi.org/10.1016/0378-1119(96)00147-3

IF: 3.913

1996-10-10

Gene

Abstract:
The role of micro RNAs let7c, 100 and 218 expression and their target RAS, C-MYC, BUB1, RB, SMARCA5, LAMB3 and Ki-67 in prostate cancer

Sabrina T. Reis,Luciana S. Timoszczuk,José Pontes-Junior,Nayara Viana,Iran A. Silva,Nelson Dip,Miguel Srougi,Katia R.M. Leite,ST Reis,LS Timoszczuk,J Pontes-Junior,N Viana,IA Silva,N Dip,M Srougi,KR Leite

DOI: https://doi.org/10.6061/clinics/2013(05)12

IF: 2.898

2013-05-17

Clinics

Abstract:OBJECTIVE: The aim of this study is to verify the expression of proteins that are controlled by miR-let7c, 100 and 218 using immunohistochemistry in tissue microarray representative of localized and metastasized the lymph nodes and bone prostate cancer.METHODS: To verify the expression of proteins that are controlled by miR-let7c (C-MYC, BUB1, RAS) 100 (SMARCA5, RB) and 218 (LAMB3) and cell proliferation (Ki-67) we used immunohistochemistry and computerized image system ImageJ MacBiophotonics in three tissue microarrays representative of localized prostate cancer and lymph node and bone metastases. miRNA expression was evaluated by qRT-PCR using 60 paraffin blocks to construct the tissue microarray representative of localized disease.RESULTS: RAS expression was increased in localized prostate cancer and bone metastases compared to the lymph nodes (p=0.017). RB showed an increase in expression from localized prostate cancer to lymph node and bone metastasis (p=0.036). LAMB3 was highly expressed in localized and lymph node metastases (p<0.001). Cell proliferation evaluated by Ki-67 showed an increase from localized prostate cancer to metastases (p<0.001). We did not found any relationship between C-MYC (p=0.253), BUB1 (p=0.649) and SMARCA5 (p=0.315) protein expression with prognosis or tumor behavior.CONCLUSION: We found that the expression of RAS, RB, LAMB3 and Ki-67 changed in the different stages of prostate cancer. Furthermore, we confirmed the overexpression of the miRNAs let7c, 100 and 218 in localized prostate cancer but failed to show the control of protein expression by the putative controller miRNAs using immunohistochemistry.

medicine, general & internal
Prognostic Significance and Relationship with the Tumor Immune Microenvironment

Juan C. de Vicente,Paloma Lequerica-Fernández,Juan P. Rodrigo,Tania Rodríguez-Santamarta,Verónica Blanco-Lorenzo,Llara Prieto-Fernández,Daniela Corte-Torres,Aitana Vallina,Francisco Domínguez-Iglesias,Saúl Álvarez-Teijeiro,Juana M. García-Pedrero

DOI: https://doi.org/10.3390/ijms25084314

IF: 5.6

2024-04-14

International Journal of Molecular Sciences

Abstract:Lectin-like transcript-1 (LLT1) expression is detected in different cancer types and is involved in immune evasion. The present study investigates the clinical relevance of tumoral and stromal LLT1 expression in oral squamous cell carcinoma (OSCC), and relationships with the immune infiltrate into the tumor immune microenvironment (TIME). Immunohistochemical analysis of LLT1 expression was performed in 124 OSCC specimens, together with PD-L1 expression and the infiltration of CD20+, CD4+, and CD8+ lymphocytes and CD68+ and CD163+-macrophages. Associations with clinicopathological variables, prognosis, and immune cell densities were further assessed. A total of 41 (33%) OSCC samples showed positive LLT1 staining in tumor cells and 55 (44%) positive LLT1 in tumor-infiltrating lymphocytes (TILs). Patients harboring tumor-intrinsic LLT1 expression exhibited poorer survival, suggesting an immunosuppressive role. Conversely, positive LLT1 expression in TILs was significantly associated with better disease-specific survival, and also an immune-active tumor microenvironment highly infiltrated by CD8+ T cells and M1/M2 macrophages. Furthermore, the combination of tumoral and stromal LLT1 was found to distinguish three prognostic categories (favorable, intermediate, and adverse; p = 0.029, Log-rank test). Together, these data demonstrate the prognostic relevance of tumoral and stromal LLT1 expression in OSCC, and its potential application to improve prognosis prediction and patient stratification.

biochemistry & molecular biology,chemistry, multidisciplinary
The effect of kindling of different nuclei in the left and right amygdala on anxiety in the rat

R. Adamec,H. Morgan

DOI: https://doi.org/10.1016/0031-9384(94)90002-7

1994-01-31

Abstract:
Alkaptonuric arthritis; report of a case.

S. Sacks

DOI: https://doi.org/10.1302/0301-620X.33B3.407

1951-08-01

Journal of Bone and Joint Surgery - British Volume

Abstract:
Abstract LB-275: Single Cell Analysis Identified LY6D As a Novel Marker of Castration-Resistant Multipotent Luminal Progenitors

Douglas E. Linn,João Barros-Silva,Guoji Guo,Michael Brown,Garry Ashton,Noel W. Clarke,Guo-Cheng Yuan,Stuart H. Orkin,Esther Baena,Zhe Li

DOI: https://doi.org/10.1158/1538-7445.am2016-lb-275

IF: 11.2

2016-01-01

Cancer Research

Abstract:Abstract The cellular origin of castration-resistant prostate cancer (CRPC) remains largely unsolved. We compared single-cell expression profiles of prostate cells sorted from hormone-naïve and castrated mice. Our single-cell analysis reveals that the prostate luminal lineage is highly heterogeneous. A subset of prostate cells in the luminal lineage characterized by high expression levels of luminal lineage markers including cytokeratin 8 (Krt8) and androgen receptor (Ar) genes, as well as prostate stem/progenitor marker genes (e.g., Trop2/Tacstd2, Sca1/Ly6a), and intermediate levels of basal genes (e.g. Trp63, Krt5), is enriched upon castration. We validated LY6D as a novel marker of castration-resistant (CR) multipotent luminal progenitor. Organoid culture revealed that LY6D+ prostate cells, including LY6D+ prostate luminal cells, were enriched with multipotent organoid-forming cells under androgen-deprivation. Lineage-tracing using Krt8-CreER mice revealed that in wild-type mice, LY6D+ CR luminal cells appeared to produce LY6D- luminal cells upon regeneration; however, when under the Pten-loss background, LY6D+ Pten-null luminal cells gave rise to LY6D+ luminal cancer cells. Furthermore, upon induced loss of Pten, prostate cancers originating from Krt8+ CR luminal cells were LY6D+ high-grade and were more advanced than those originating from hormone-naïve luminal cells. Lastly, in prostate cancer patients, LY6D amplification/upregulation correlates with advanced disease. Overall, our results uncover the luminal lineage heterogeneity and identify LY6D as a novel tumor-initiating cell marker of CRPC. Citation Format: Douglas E. Linn, João Barros-Silva, Guoji Guo, Michael Brown, Garry Ashton, Noel W. Clarke, Guo-Cheng Yuan, Stuart H. Orkin, Esther Baena, Zhe Li. Single cell analysis identified LY6D as a novel marker of castration-resistant multipotent luminal progenitors. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr LB-275.
Chronic motor cortex stimulation for movement disorders: A promising perspective

A. Franzini,P. Ferroli,I. Dones,C. Marras,G. Broggi

DOI: https://doi.org/10.1179/016164103101201265

2003-03-01

Neurological Research

Abstract:Abstract Five patients affected by thalamic hand and intentional myoclonus have been evaluated and selected for chronic motor cortex stimulation. A quadripolar electrode strip was placed epidurally under local anesthesia through an MR-image-guided single precentral burr hole placed following the morphologic recognition of the central sulcus. Intra-operative stimulation was used to induce muscle contraction at the affected site to confirm the correct placement of the electrode. A one-week trial period preceded the implant of an internal pace-maker under general anesthesia. A remarkable decrease in pain was reported by four patients together with the reduction of dystonia and rigidity in thalamic hand and marked decrease of intentional myoclonus. No complications or undesired side effects of electrode implant and stimulation were observed.
Abstract 1147: Sub-cellular spatial resolution of immune and stromal interactions underlying prostate cancer progression

Chia-Kuei Mo,Reyka G. Jayasinghe,Ateih Abedin do,Xiang Li,Cody Weimholt,Eric H. Kim,Russell Pachynski,Feng Chen,Li Ding

DOI: https://doi.org/10.1158/1538-7445.am2024-1147

IF: 11.2

2024-03-24

Cancer Research

Abstract:Prostate cancer boasts a complex morphological structure and diverse cellular composition, yet current technology falls short in resolving the detailed spatial interactions among cells within the environment. In this study, we employed the Xenium platform, coupled with the 3D reconstruction tool Mushroom, to examine high-resolution spatial cellular interactions within the prostate cancer microenvironment. Our investigation focused on the transition of molecular characteristics from normal to high-grade prostatic intraepithelial neoplasia (HGPIN, pre-cancer), spanning the spectrum of Gleason Grades 3 to 4 and advancing to metastatic prostate cancer. We identified genes with unique spatial and grade-dependent expression profiles, including MYC, CP, and UHCL1. Evaluating sub-cellular imaging facilitated a comprehensive characterization and quantification of immune and stromal interactions, unveiling distinct spatial niches across transition stages. These findings underscore the nuanced immune interactions within the tumor microenvironment and offer crucial insights into the development of immunotherapeutic approaches tailored to the specific spatial and immune dynamics observed in advanced prostate cancer. This research contributes to the evolving understanding of prostate cancer progression, providing a foundation for the development of targeted therapies that disrupt specific cellular interactions. Citation Format: Chia-Kuei Mo, Reyka G. Jayasinghe, Ateih Abedin do, Xiang Li, Cody Weimholt, Eric H. Kim, Russell Pachynski, Feng Chen, Li Ding. Sub-cellular spatial resolution of immune and stromal interactions underlying prostate cancer progression [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 1147.

oncology
Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.

Guanxiong Ding,Jie Fang,Shijun Tong,Lianxi Qu,Haowen Jiang,Qiang Ding,Jun Liu

DOI: https://doi.org/10.1002/pros.22978

2015-01-01

Abstract:BACKGROUNDMetastasis is the primary cause of prostate cancer (PCa) lethality and poses a huge clinical obstacle. Lipocalin 2 (LCN2), a member of the lipocalin family, is aberrantly expressed in some human cancers and has been implicated in the progression of some tumors. However, the role of LCN2 in the metastatic capacity of prostate cancer (PCa) is poorly understood. METHODSLCN2 expression was examined by RT-qPCR and/or immunoblotting in human prostate tissue specimens and prostate cancer cell lines LNCaP, C4-2, 22RV1, PC3, DU-145, and PC3MM2. LCN2 protein level in human serum samples was determined by ELISA. Lentiviruses-mediated over-expression of LCN2 and knockdown of LCN2 was conducted to evaluate the role of LCN2 in cell migratory and invasive capacities of prostate cancer cells. Cell migration and invasion was examined by transwell chamber assay. Knockdown of SLUG by lentivirus was performed to investigate its role in LCN2-promoted cell migration and invasion in vitro (22RV1 cell line) and metastasis in vivo (tail vein metastasis assay in nude mice). Role of ERK signaling in LCN2-mediated up-regulation of SLUG was assayed by using ERK inhibitor U0126. RESULTSWe confirmed that LCN2 levels were correlated positively with invasive prostate cancer in human tissue and serum samples, and were also consistently associated with the invasive capacity of prostate cancer cell lines. The over-expression of LCN2 in 22RV1 cells (not highly invasive) promoted the epithelial-mesenchymal transition (EMT), increasing cell motility and invasiveness, while the knockdown of LCN2 in PC3 cells (highly invasive) inhibited EMT, decreasing cell motility and invasiveness. Among the multiple EMT transcription factors, LCN2 specifically induces the expression of SLUG, which was shown here to be required for the LCN2-induced increase in the invasive capacity of prostate cancer cells both in vitro and in vivo. Mechanistically, LCN2 promoted SLUG expression via activating ERK signaling pathway. CONCLUSIONLCN2 plays an important role in promoting cell migration and invasion of prostate cancer by inducing EMT through the ERK/SLUG axis. Therefore, targeted inhibition of LCN2 may represent a therapeutic strategy to prevent the metastasis of prostate cancer. Prostate 75:957-968, 2015. (c) 2015 Wiley Periodicals, Inc.
Massive hemoptysis complicating Behçet's syndrome: the importance of early pulmonary angiography and operation.

F. Salamon,Abraham Weinberger,M. Nili,I. Avidor,M. Neuman,A. Zelikovsky,Morris J. Levy,J. Pinkhas

DOI: https://doi.org/10.1016/S0003-4975(10)64538-9

1988-05-01

Abstract:
Single-Cell Analysis Identifies LY6D As a Marker Linking Castration-Resistant Prostate Luminal Cells to Prostate Progenitors and Cancer.

João D. Barros-Silva,Douglas E. Linn,Ivana Steiner,Guoji Guo,Adnan Ali,Hubert Pakula,Garry Ashton,Isabel Peset,Michael Brown,Noel W. Clarke,Roderick T. Bronson,Guo-Cheng Yuan,Stuart H. Orkin,Zhe Li,Esther Baena

DOI: https://doi.org/10.1016/j.celrep.2018.11.069

IF: 8.8

2018-01-01

Cell Reports

Abstract:The exact identity of castrate-resistant (CR) cells and their relation to CR prostate cancer (CRPC) is unresolved. We use single-cell gene profiling to analyze the molecular heterogeneity in basal and luminal compartments. Within the luminal compartment, we identify a subset of cells intrinsically resistant to castration with a bi-lineage gene expression pattern. We discover LY6D as a marker of CR prostate progenitors with multipotent differentiation and enriched organoid-forming capacity. Lineage tracing further reveals that LY6D+ CR luminal cells can produce LY6D− luminal cells. In contrast, in luminal cells lacking PTEN, LY6D+ cells predominantly give rise to LY6D+ tumor cells, contributing to high-grade PIN lesions. Gene expression analyses in patients’ biopsies indicate that LY6D expression correlates with early disease progression, including progression to CRPC. Our studies thus identify a subpopulation of luminal progenitors characterized by LY6D expression and intrinsic castration resistance. LY6D may serve as a prognostic maker for advanced prostate cancer.

Isotope effect and pressure dependence of the freezing temperature in proton glasses.

Lumican affects tumor cell functions, tumor–ECM interactions, angiogenesis and inflammatory response

Multi-omics analysis reveals the prognostic and tumor micro-environmental value of lumican in multiple cancer types

Proteomic and Phosphoproteomic Maps of Lung Squamous Cell Carcinoma from Chinese Patients.

Psychiatric Commitment of the Elderly

Lumican deficiency promotes pulmonary arterial remodeling

Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment.

Lumican suppresses cell proliferation and aids Fas-Fas ligand mediated apoptosis: implications in the cornea

Exploring molecular structure by virtual reality.

Mechanisms of Tumor-Lymphatic Interactions in Invasive Breast and Prostate Carcinoma

Cloning and upstream sequence of a juvenile hormone-regulated gene from the migratory locust.

The role of micro RNAs let7c, 100 and 218 expression and their target RAS, C-MYC, BUB1, RB, SMARCA5, LAMB3 and Ki-67 in prostate cancer

Prognostic Significance and Relationship with the Tumor Immune Microenvironment

The effect of kindling of different nuclei in the left and right amygdala on anxiety in the rat

Alkaptonuric arthritis; report of a case.

Abstract LB-275: Single Cell Analysis Identified LY6D As a Novel Marker of Castration-Resistant Multipotent Luminal Progenitors

Chronic motor cortex stimulation for movement disorders: A promising perspective

Abstract 1147: Sub-cellular spatial resolution of immune and stromal interactions underlying prostate cancer progression

Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.

Massive hemoptysis complicating Behçet's syndrome: the importance of early pulmonary angiography and operation.

Single-Cell Analysis Identifies LY6D As a Marker Linking Castration-Resistant Prostate Luminal Cells to Prostate Progenitors and Cancer.